HOME >> BIOLOGY >> NEWS
New studies advance scientific knowledge of drinking water disinfection byproducts

BETHESDA, MD (October 15, 2002) In its September/October issue, the International Journal of Toxicology is pleased to publish the last in a series of four studies examining possible reproductive and developmental health effects from two byproducts of drinking water chlorination. These studies fill significant data gaps identified by a Federal Advisory Committee formed by the U.S. Environmental Protection Agency (EPA) on drinking water regulations.

Small amounts of disinfection byproducts, including bromodichloromethane (BDCM) and dibromoacetic acid (DBA), are formed in drinking water when chlorine disinfectants combine with naturally occurring organic matter. Several epidemiology studies have reported a possible association between these byproducts and adverse reproductive outcomes, including spontaneous abortion. Because the existing toxicology data was very limited, the Federal Advisory Committee recommended that BDCM, in particular, should be thoroughly studied for a potential causal relationship to reproductive and developmental toxicity.

To address these data gaps, researchers at Argus Research Laboratories examined laboratory animals exposed to BDCM and DBA through drinking water. Each study found no adverse effects at dose levels thousands of times higher than those to which humans are exposed. Based on the results of these studies, the researchers concluded that BDCM and DBA are unlikely to pose a reproductive or developmental health risk to humans. EPA will review this research as it develops new regulations on disinfection byproducts.

The studies were designed to comply with the EPA's Federal Insecticide Fungicide and Rodenticide Act (FIFRA) Guidelines and with the EPA's Guidelines for Good Laboratory Practices. Each study was independently monitored. In addition, an independent panel of experts reviewed the study designs and interpretation of data. The studies were sponsored by the Research Foundation for Health and Env
'"/>

Contact: Dr. Bruce Bernard
bernard@sra-intl.com
202-728-1400
International Journal of Toxicology
15-Oct-2002


Page: 1 2 3

Related biology news :

1. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
2. UCSD undergraduates participate in collaborative studies abroad on cyberinfrastructure
3. Scientist honored for studies of genetic influence on chemotherapy, tumor development
4. $5 million grant funds partnership, studies of minority-based issues in reproductive health
5. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
6. $5.5 million awarded to tree-ring research and climate studies
7. Pancreatic cancer blood test & gene studies show promise
8. Two studies weigh in on low-carb diets
9. Animal studies show promise treating severe chronic pain
10. New studies show Curves Program raises metabolic rate in overweight and sedentary women
11. Florida Tech researchers win $912,700 grant for cell studies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... 01, 2020 , ... AltruBio Inc. http://www.altrubio.com , a ... for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European Hematology Association ... of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase 1 single ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
(Date:6/25/2020)... , ... June 24, 2020 , ... ... enterprise software and software-driven clinical data services that accelerate drug development, is collaborating ... selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter ... of a successful study, while protecting and accessing the catheter or device post-surgery is ... from Envigo in a live webinar on Wednesday, August 5, ...
(Date:7/18/2020)... ... July 16, 2020 , ... Medial EarlySign ... detection and prevention of high-burden diseases, and Centric Consulting, a business and technology ... to utilize existing data in order to identify and prioritize patients for care. ...
(Date:7/10/2020)... ... 2020 , ... Bode Technology, a leading provider ... through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical testing ... provides a turnkey solution that includes a comprehensive collection and virus-management program for ...
(Date:7/10/2020)... ... July 09, 2020 , ... In ... commonly used to suppress pigment formation in zebrafish embryos, maintaining optical transparency to ... by Dr MA has been using the zebrafish model to investigate the causes ...
Breaking Biology Technology:
Cached News: